Address: 3F, 216 Wenlin North Road, Peitou, Taipei, Taiwan
Tel: (02)2821-7057
Web: http://www.naturewise.com.tw/e-Company.htm
Since incorporation, NatureWise Biotech & Medicals Corp. (NBM) has striven for excellence, innovation and breakthroughs in the field of botanical and health food products. The company seeks to be the global leader in the development of natural medicine. NBM is the first biotech company in Taiwan that completed the Phase III clinical study on Novel Chinese medicine according to Good Clinical Practice (GCP) standards and received the first Permit for Novel Chinese Medicine. The company received many patents and awards, including the gold award for R&D from Taipei Biotech Awards. In addition, the R&D team has developed several health foods with patented ingredients as the base in novel drug development to increase revenue.
Other than the development of natural medicine, NBM is also committed to the development of single-entity new drugs; lead compounds have been obtained and is focused on the development of, HDAC inhibitors, a new drug for cancer and degenerative neurological diseases.
Where is NatureWise most focused today as a company? NatureWise is mainly focused on histone deacetylase (HDAC) inhibitors, especially in the new area of anti-cancer target therapy. These HDAC inhibitor…
Chairman of Abnova Corporation Wilber Huang discusses the company’s core strengths, Taiwan’s bilateral relationship with China’s biotech industry, and offers some advice to future start-up biotech companies in Taiwan. Abnova…
The chairman of Bionet reflects on past market challenges and the growing strength of Bionet’s reach both domestically and globally, and why Taiwan is the perfect size for a biotech…
Taiwan’s current health minister reflects on Taiwan’s prestigious healthcare system, the problems in the first generation health insurance system that were fixed in the second, and strategies to rectify the…
Jaw-Jou Kang, former Director General of Taiwan Food & Drug Administration (TFDA) discusses the key successes the company has had since 2010, where it is looking to in the future…
The Deputy Executive Secretary of Taiwan’s National Development Fund discusses the recent shift in focus from semiconductors to biotech investments; why this has been a huge success thus far and…
The Vice President of Merits Health Products discusses the company’s main opportunities and challenges of the past 25 years, which countries are among its top buyers and its future plans…
YFY Biotech Management Company has not always been involved in the biotech sector. How has it evolved over the years? Yuen Foong Yu Group originally began as a paper mill…
Dr. Chen, you joined US-based Anchen Pharmaceuticals in 2009 to help the company form a spin-off in Taiwan. Why did a US-based company look to establish itself in Taiwan, and…
Over the past decade since its founding, what are some of the highlights in the transformation of Taiwan Advance Bio-Pharmaceutical Inc. (TABP) into a well established company? TABP was founded…
Mr. Lin, you enjoyed a decades-long career in the ICT industry before making the transition to healthcare. What can you tell our readers about the evolution of General Biologics Corp.…
Formosa Laboratories is one of Taiwan’s international pioneers in small molecules, entering the global arena at a very early stage. How did that decision come about? Generally speaking, Taiwan’s API…
PAREXEL has been in Asia Pacific (APAC) since the company entered Japan in 1995. It chose Taiwan as its regional base of operations with the 2007 acquisition of APEX, a…
See our Cookie Privacy Policy Here
